Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
9.86
-0.13 (-1.35%)
Jul 1, 2026, 2:39 PM EDT - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $970.22 million as of July 1, 2026. Its market cap has increased by 149.35% in one year.
Market Cap
970.22M
Enterprise Value
623.50M
1-Year Change
149.35%
Ranking
Category
Stock Price
$9.86
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $970.22M, an increase of 28.66%. That is a compound annual growth rate of 3.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 970.22M | 120.81% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 985.09M |
| Kura Oncology | 973.85M |
| DBV Technologies | 967.91M |
| Pharming Group | 947.75M |
| Replimune Group | 940.19M |
| LB Pharmaceuticals | 936.01M |
| Janux Therapeutics | 934.59M |
| Arbutus Biopharma | 924.48M |